ABUS
Arbutus Biopharma Corp
4.90$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.67 | 0.55 | 0.03 | 0.20 | 0.11 | 0.11 | 0.09 | 0.10 | 0.26 | 0.11 | 0.03 | 0.07 | |
| 1.72 | 1.13 | 1.16 | 1.15 | 1.05 | 1.01 | 0.63 | 0.02 | 0.01 | 0.44 | 0.01 | 0.00 | |
| -1.06 | -0.59 | -1.13 | -0.95 | -0.94 | -0.90 | -0.53 | 0.10 | 0.26 | 0.11 | 0.03 | 0.07 | |
| 1.72 | 1.13 | 1.16 | 1.15 | 1.05 | 1.01 | 0.65 | 0.62 | 0.56 | 0.44 | 0.29 | 0.13 | |
| 0.39 | 0.58 | 0.74 | 0.29 | 0.29 | 0.31 | 0.20 | 0.16 | 0.12 | 0.14 | 0.12 | 0.08 | |
| 2.13 | 1.73 | 1.92 | 1.48 | 1.38 | 1.62 | 0.23 | 0.80 | 0.69 | 0.58 | 0.44 | 0.21 | |
| -1.47 | -2.25 | -9.27 | -2.03 | -1.62 | -2.52 | -0.76 | -0.69 | -0.43 | -0.47 | -0.41 | -0.14 | |
| 0.04 | 0.01 | 0.03 | 0.00 | 0.00 | 0.04 | 0.05 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | |
| -1.72 | -1.70 | -9.22 | -1.99 | -1.11 | -2.91 | -0.84 | -0.72 | -0.43 | -0.44 | -0.38 | -0.17 | |
| 0.00 | -0.36 | -1.98 | -0.44 | -0.08 | -0.22 | 0.02 | 0.01 | 0.03 | 0.00 | – | – | |
| -1.73 | -1.34 | -7.24 | -1.54 | -1.03 | -2.69 | -0.84 | -0.72 | -0.46 | -0.44 | -0.38 | -0.17 | |
| -1.45 | -1.69 | -9.20 | -1.95 | -1.07 | -2.84 | -0.76 | -0.67 | -0.41 | -0.43 | -0.37 | -0.17 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.